Full Press Release Details
REGENERON REPORTS POSITIVE PHASE 3 DATA FOR IL-1 TRAP IN CAPS IL-1 Trap (rilonacept) Markedly Reduced Disease Activity in Patients with Rare Chronic Autoinflammatory Disease.
REGN
REGENERON REPORTS POSITIVE PHASE 3 DATA FOR IL-1 TRAP IN CAPS IL-1 Trap (rilonacept) Markedly Reduced Disease Activity in Patients with Rare Chronic Autoinflammatory Disease
Key Takeaway: REGENERON REPORTS POSITIVE PHASE 3 DATA FOR IL-1 TRAP IN CAPS IL-1 Trap (rilonacept) Markedly Reduced Disease Activity in Patients with Rare Chronic Autoinflammatory Disease